A mortality model is evaluated in five retrospective bypass-surgery cohorts
Source check: Source checked. Not independent scientific confirmation.
Finding: A three-learner ensemble evaluated recorded mortality after isolated coronary bypass surgery. It reported AUCs of 0.9145 in a 952-person internal test and 0.8585 and 0.8553 in two additional hospital cohorts. These retrospective results do not establish a preoperative warning system or improved care.
Technology: XGBoost; CatBoost; LightGBM ensemble
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- XGBoost,CatBoost and LightGBM classifiers were trained and combined as the XCL ensemble to estimate recorded postoperative mortality.
- Test and result
- A 4,764-person pool from three hospitals was split into 3,812 development and 952 internal-test records. Additional hospital cohorts contained 1,733 and 415 patients. The outcome was death within 30 days or during postoperative hospitalization.
- Limitation / still unknown
- Inputs include perioperative variables, and an exclusively preoperative prediction time is unestablished. Optimal thresholds used Youden indices; model/threshold comparisons do not establish locked prospective performance. Low event counts, retrospective missing-data exclusions and an Asian cohort limit generalization. AUC differences and decision-curve analyses do not demonstrate clinical benefit or causal effects.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11471463/ · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC11471463/unicode
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Original clinical eligibility/outcome/model design and external-cohort discrimination Results;current PubMed bibliographic metadata.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.